ARCHIVES

From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

Senate Appropriations Committee Earmarks $118 Million for Centers, Orders Full Grant Funding

October 9, 1987

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Broder, Herberman, Decline To Coauthor Reanalysis of Data

September 9, 1994

Declining Support Among Oncologists For Euthanasia.

October 13, 2000